News
Celltrion receives EC approval for Avtozma, a biosimilar to RoActemra
The European Commission (EC) has granted marketing authorization for Celltrion's Avtozma (CT-P47), a biosimilar referencing RoActemra (tocilizumab).
Avtozma has been approved for all indications of its...
hVIVO acquires Cryostore for up to £3.2m
hVIVO, an early-stage Contract Research Organisation (CRO), has acquired Cryostore, a specialist provider of high industry standard, temperature-controlled storage solutions for biological and clinical...
Incyte and Genesis Therapeutics enter strategic collaboration focused on novel small molecule medicines
Incyte and Genesis Therapeutics have entered into a strategic collaboration focused on the research, discovery and development of novel small molecule medicines, with an initial...
